槲皮素治疗甲状腺癌的研究进展
摘要
关键词
全文:
PDF参考
[1]渠宁，王钰婷，马奔，et al. 2022 年度甲状腺癌研究及诊疗新进展 [J]. 中国癌症杂志，2023，33（05）：423-30.
[2]ZENG H，ZHENG R，SUN K，et al. Cancer survival statistics in China 2019-2021：a multicenter，population-based study [J]. J Natl
Cancer Cent，2024，4（3）：203-13.
[3]ALIZADEH S R，EBRAHIMZADEH M A. Quercetin derivatives：Drug design，development，and biological activities，a review [J].
Eur J Med Chem，2022，229：114068.
[4]SINGH P，ARIF Y，BAJGUZ A，et al. The role of quercetin in plants [J]. Plant Physiol Biochem，2021，166：10-9.
[5]BOYER J，BROWN D，LIU R H. In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the
Caco-2 cell monolayer [J]. Nutr J，2005，4：1.
[6]QI W，QI W，XIONG D，et al. Quercetin：Its Antioxidant Mechanism，Antibacterial Properties and Potential Application in Prevention
and Control of Toxipathy [J]. Molecules，2022，27（19）.
[7]TANG S M，DENG X T，ZHOU J，et al. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
[J]. Biomed Pharmacother，2020，121：109604.
[8]WU J，LV T，LIU Y，et al. The role of quercetin in NLRP3-associated inflammation [J]. Inflammopharmacology，2024，32（6）：
3585-610.
[9]DI PETRILLO A，ORRU G，FAIS A，et al. Quercetin and its derivates as antiviral potentials：A comprehensive review [J]. PhytotherRes，2022，36（1）：266-78.
[10]KHAN H，ULLAH H，ASCHNER M，et al. Neuroprotective Effects of Quercetin in Alzheimer's Disease [J]. Biomolecules，2019，
10（1）.
[11]SHEN P，LIN W，DENG X，et al. Potential Implications of Quercetin in Autoimmune Diseases [J]. Front Immunol，2021，12：
689044.
[12]ZAPLATIC E，BULE M，SHAH S Z A，et al. Molecular mechanisms underlying protective role of quercetin in attenuating
Alzheimer's disease [J]. Life Sci，2019，224：109-19.
[13]ZHANG W，ZHENG Y，YAN F，et al. Research progress of quercetin in cardiovascular disease [J]. Front Cardiovasc Med，2023，
10：1203713.
[14]DEEPIKA，MAURYA P K. Health Benefits of Quercetin in Age-Related Diseases [J]. Molecules，2022，27（8）.
[15]KANG H J，YOUN Y K，HONG M K，et al. Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol
phytochemicals [J]. J Korean Med Sci，2011，26（7）：893-9.
[16]QUAGLIARIELLO V，ARMENIA E，AURILIO C，et al. New Treatment of Medullary and Papillary Human Thyroid Cancer：
Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase [J]. J
Cell Physiol，2016，231（8）：1784-95.
[17]MUTLU ALTUNDAG E，KASACI T，YILMAZ A M，et al. Quercetin-Induced Cell Death in Human Papillary Thyroid Cancer
（B-CPAP）Cells [J]. J Thyroid Res，2016，2016：9843675.
[18]GONCALVES C F L，HECHT F，CAZARIN J，et al. The flavonoid quercetin reduces cell migration and increases NIS and
E-cadherin mRNA in the human thyroid cancer cell line BCPAP [J]. Mol Cell Endocrinol，2021，529：111266.
[19]HONG Y，LEE J，MOON H，et al. Quercetin Induces Anticancer Activity by Upregulating Pro-NAG-1/GDF15 in Differentiated
Thyroid Cancer Cells [J]. Cancers（Basel），2021，13（12）.
[20]FERRY D R，SMITH A，MALKHANDI J，et al. Phase I clinical trial of the flavonoid quercetin：pharmacokinetics and evidence for
in vivo tyrosine kinase inhibition [J]. Clin Cancer Res，1996，2（4）：659-68.
[21]MULHOLLAND P J，FERRY D R，ANDERSON D，et al. Pre-clinical and clinical study of QC12，a water-soluble，pro-drug of
quercetin [J]. Ann Oncol，2001，12（2）：245-8.
[22]PHAM T N D，STEMPEL S，SHIELDS M A，et al. Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing
hnRNPA1 [J]. Int J Mol Sci，2019，20（17）.
[23]CELANO M，MAGGISANO V，BULOTTA S，et al. Quercetin improves the effects of sorafenib on growth and migration of thyroid
cancer cells [J]. Endocrine，2020，67（2）：496-8.
[24]MUTLU ALTUNDAG E，MINE YILMAZ A，KASACI T，et al. The role of HSP90 in Quercetin-induced apoptosis in human papillary
thyroid（B-CPAP）cancer cells [J]. Free Radic Biol Med，2014，75 Suppl 1：S43.
[25]SUN Y，XIE W，KANG N，et al. To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network
Pharmacology and Experiments [J]. Dis Markers，2022，2022：9541080.
[26]BHAT A A，THAPA R，AFZAL O，et al. The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer：A
Review [J]. Int J Biol Macromol，2023，242（Pt 2）：124832.
[27]YANG M H，KIM J，KHAN I A，et al. Nonsteroidal anti-inflammatory drug activated gene-1（NAG-1）modulators from natural
products as anti-cancer agents [J]. Life Sci，2014，100（2）：75-84.
[28]BABAEI G，AZIZ S G，JAGHI N Z Z. EMT，cancer stem cells and autophagy；The three main axes of metastasis [J]. Biomed
Pharmacother，2021，133：110909.[29]RIESCO-EIZAGUIRRE G，SANTISTEBAN P，DE LA VIEJA A. The complex regulation of NIS expression and activity in thyroid
and extrathyroidal tissues [J]. Endocr Relat Cancer，2021，28（10）：T141-T65.
[30]OH J M，AHN B C. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer：Impaired sodium
iodide symporter（NIS）expression owing to altered signaling pathway activity and intracellular localization of NIS [J]. Theranostics，
2021，11（13）：6251-77.
[31]MENG Y，LIN W，WANG N，et al. Bazedoxifene-induced ROS promote mitochondrial dysfunction and enhance osimertinib
sensitivity by inhibiting the p-STAT3/SOCS3 and KEAP1/NRF2 pathways in non-small cell lung cancer [J]. Free Radic Biol Med，
2023，196：65-80.
[32]YU C，FAN Y，ZHANG Y，et al. LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3
pathway [J]. Cancer Cell Int，2022，22（1）：228.
[33]韩克，董保华，孟佳佳，et al. 槲皮素调控 SOCS3/STAT3 信号通路对甲状腺乳头状癌细胞生物学行为的影响 [J]. 河北医
学，2023，29（09）：1415-20.
[34]PENG Y，YANG H，LI S. The role of glycometabolic plasticity in cancer [J]. Pathol Res Pract，2021，226：153595.
[35]连莲，杨志坚，杨波，et al. 槲皮素抑制 Akt/mTOR 相关糖酵解影响甲状腺癌 TPC-1 细胞侵袭迁移的研究 [J]. 中华肿瘤
防治杂志，2023，30（11）：639-46+61.
[36]HAIDER T，PANDEY V，BANJARE N，et al. Drug resistance in cancer：mechanisms and tackling strategies [J]. Pharmacol Rep，
2020，72（5）：1125-51.
[37]BUKOWSKI K，KCIUK M，KONTEK R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy [J]. Int J Mol Sci，2020，21（9）.
[38]ABDU S，JUAID N，AMIN A，et al. Effects of Sorafenib and Quercetin Alone or in Combination in Treating Hepatocellular
Carcinoma：In Vitro and In Vivo Approaches [J]. Molecules，2022，27（22）.
[39]ZHANG J，SHEN L，LI X，et al. Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response
through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer [J]. ACS Nano，2019，13（11）：12511-24.
[40]XU L，LI H L，WANG L P. PH-Sensitive，Polymer Functionalized，Nonporous Silica Nanoparticles for Quercetin Controlled Release
[J]. Polymers（Basel），2019，11（12）.
[41]QURESHI W A，ZHAO R，WANG H，et al. Co-delivery of doxorubicin and quercetin via mPEG–PLGA copolymer assembly for
synergistic anti-tumor efficacy and reducing cardio-toxicity [J]. 科学通报：英文版，2016，（21）：10.
[42]PRITAM，SADHUKHAN，MOUSUMI，et al. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast
cancer therapy [J]. Materials Science & Engineering C，2019.
[43]杜倩，汤洋，陈剑秋，et al. 槲皮素和白藜芦醇共载磁性固体脂质纳米粒的制备及其抑瘤作用评价 [J]. 中国实验方剂学
杂志，2019，（10）：6.
[44]Shin H，Hwang K，Choi K. Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers[J]. Nutrients，2019，
11（1）：125.
[45]Hee Joon Kang Y Y M H. Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals[J]. J
Korean Med Sci，2011，26（7）：893–899
[46]Staedler D，Idrizi E，Kenzaoui B H，et al. Drug combinations with quercetin：doxorubicin plus quercetin in human breast cancer
cells[J]. Cancer Chemother Pharmacol，2011，68（5）：1161-1172.
[47]Vargas A J，Burd R. Hormesis and synergy：pathways and mechanisms of quercetin in cancer prevention and management[J]. Nutr
Rev，2010，68（7）：418-428.
[48]周乐. 联合近红外荧光分子肿瘤靶向探针的热效应与免疫因子协同治疗甲状腺肿瘤的研究[D]. 吉林大学，2016. 59 页
(16 摘要 Views, 45 PDF Downloads)
Refbacks
- 当前没有refback。